35.74
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
10.84%
36.52
|
32.94 | 31.45 | 31.85 | 29.74 |
| Operating Income/Loss |
10.84%
-36.52
|
-32.94 | -31.45 | -31.85 | -29.74 |
| Nonoperating Income/Loss |
12.81%
2.682
|
3.076 | 3.354 | 3.703 | 4.173 |
| Income/Loss From Continuing Operations Before Tax |
13.28%
-33.83
|
-29.87 | -28.10 | -28.15 | -25.57 |
| Income/Loss From Continuing Operations After Tax |
13.28%
-33.83
|
-29.87 | -28.10 | -28.15 | -25.57 |
|
|
13.28%
-33.83
|
-29.87 | -28.10 | -28.15 | -25.57 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.87%
0.0784
|
59.67 | 59.55 | 59.34 | 0.6187 |
| Diluted Average Shares |
99.87%
0.0784
|
59.67 | 59.55 | 59.34 | 0.6187 |
| Basic Earnings Per Share |
12.00%
-0.56
|
-0.50 | -0.47 | -0.47 | -0.43 |
| Diluted Earnings Per Share |
12.00%
-0.56
|
-0.50 | -0.47 | -0.47 | -0.43 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):